Engelbergs J, Thomale J, Galhoff A, Rajewsky M F
Institute of Cell Biology (Cancer Research), University of Essen Medical School and West German Cancer Center Essen, Hufeland-Strasse 55, D-45122 Essen, Germany.
Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1635-40. doi: 10.1073/pnas.95.4.1635.
Differential repair of structurally distinct mutagenic lesions in critical genes may influence the cellular risk of malignant conversion. We have investigated rat mammary tumorigenesis induced by N-ethyl-N-nitrosourea (EtNU) versus N-methyl-N-nitrosourea (MeNU) with respect to tumor incidence, ras gene mutation, and gene-specific repair. Both carcinogens induced mammary adenocarcinomas at high yield. In mammary epithelia (very low expression of O6-alkylguanine-DNA alkyltransferase, MGMT), O6-methylguanine (O6-MeGua) was eliminated from transcribed (H-ras and beta-actin) and inactive genes (IgE heavy chain) at the same slow rate as determined for bulk genomic DNA. The persistence of O6-MeGua in DNA correlated with a high frequency of G:C --> A:T transition mutations at codon 12 of the H-ras gene in MeNU-induced tumors. Repair of O6-ethylguanine (O6-EtGua), too, was slow in the IgE heavy chain gene as in bulk DNA. Contrasting with O6-MeGua, however, O6-EtGua was removed approximately 20 times faster from the active H-ras and beta-actin genes via MGMT-independent mechanism(s). Accordingly, no H-ras codon 12 mutations were found in EtNU-induced tumors, and 5- to 8-fold surplus alkyltransferase activity of the mammary epithelia-via a bacterial ada transgene-did not significantly counteract tumorigenesis in EtNU-exposed contrary to MeNU-treated animals. Neither MeNU- nor EtNU-induced tumors exhibited mutations at codons 13 and 61 of H-ras or codons 12, 13, and 61 of K-ras. Fast repair of O6-EtGua, but not O6-MeGua, in transcribed genes thus prevents mutational activation of H-ras when rat mammary carcinogenesis is initiated by EtNU in place of MeNU.
关键基因中结构不同的诱变损伤的差异修复可能会影响细胞恶性转化的风险。我们研究了N-乙基-N-亚硝基脲(EtNU)与N-甲基-N-亚硝基脲(MeNU)诱导的大鼠乳腺肿瘤发生情况,包括肿瘤发生率、ras基因突变和基因特异性修复。两种致癌物都能高产诱导乳腺腺癌。在乳腺上皮细胞(O6-烷基鸟嘌呤-DNA烷基转移酶,MGMT表达极低)中,O6-甲基鸟嘌呤(O6-MeGua)从转录基因(H-ras和β-肌动蛋白)和非活性基因(IgE重链)中消除的速度与在总体基因组DNA中测定的速度一样慢。DNA中O6-MeGua的持续存在与MeNU诱导的肿瘤中H-ras基因第12密码子处G:C→A:T转换突变的高频率相关。O6-乙基鸟嘌呤(O6-EtGua)在IgE重链基因中的修复也与在总体DNA中一样缓慢。然而,与O6-MeGua不同的是,O6-EtGua通过不依赖MGMT的机制从活性H-ras和β-肌动蛋白基因中去除的速度快约20倍。因此,在EtNU诱导的肿瘤中未发现H-ras第12密码子突变,并且与MeNU处理的动物相反,通过细菌ada转基因使乳腺上皮细胞的烷基转移酶活性增加5至8倍并不能显著抵消EtNU暴露后的肿瘤发生。MeNU和EtNU诱导的肿瘤在H-ras的第13和61密码子或K-ras的第12、13和61密码子处均未出现突变。因此,当大鼠乳腺致癌作用由EtNU而非MeNU引发时,转录基因中O6-EtGua而非O6-MeGua的快速修复可防止H-ras的突变激活。